Clinical trials recruiting in Grants Pass, Oregon
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 6
Conditions recruiting in Grants Pass, Oregon
Recruiting trials in Grants Pass, Oregon
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Common questions
How many clinical trials are recruiting in Grants Pass, Oregon?
7 recruiting trials have at least one study site in Grants Pass, Oregon.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.